← All funding rounds

BioVersys raises €2.6M Seed round

27 May 2009· Basel, Switzerland· health, biotech, drug_discovery, antimicrobial_resistance, b2b

To take the first step towards the development of novel therapies to overcome bacterial resistance against antibiotics.

About BioVersys

Stage

Series C

Headquarters

Basel, Switzerland

Founded

2008

Team Size

21–50

Sectors

healthbiotechdrug_discoveryantimicrobial_resistanceb2b

http://www.bioversys.com/

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEhWisrC_uxJYLXNgqAjRzUuPgJgtBxNvmZK6AVwKq-GQ4hDy50gFD7NURPRV2q6BcIpJSagGit4g8VJGNTa7mJpXCJ6dbwkkK-P6rY08-WPV9CWzRFOaUCoJR75yjkHHybj2Z1wFIGBRr3dtffWReOxFI_pSX1eJ8g2maZq0Zc_TULRaHiqTGIdPR4npq_jBB0j6apXLg2IorqHw6GSeWnEuHsJA0yGxDsu9dHIw==, https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF4YSfHxCTSYO1iH-40DvbclqOZIQIGxBU-f6VSm4rw52lV1no3SxDUqa3_hXKkinwRyv44GhoVwqPohe5BN9djjNqpMX4H81bYAF0yI_SqRHbZBX63GTqb9zHHS84ZFoCrgtQiQ_sFxa7Once1Eghf7h1m9lcT7y2Uj5k4WYJQ3jLaLM22zkNNVYXhbcai4VRZ